cifenline has been researched along with Chronic Kidney Failure in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To test the hypothesis that renal failure alters the disposition of cibenzoline in humans, an absolute bioavailability and elimination kinetic study was performed." | 2.67 | Bioavailability and kinetics of cibenzoline in patients with normal and impaired renal function. ( Aogaichi, K; Aronoff, G; Barbalas, M; Brazzell, R; Brier, M; Massarella, J; Mayer, ML; Sloan, R, 1991) |
| " The pharmacokinetic parameters observed in the healthy volunteers were similar to those reported previously." | 1.27 | Effect of renal impairment on the pharmacokinetics of cibenzoline. ( Aogaichi, K; Chow, MS; Di Persio, D; Khoo, KC; Kluger, J; Massarella, JW; Smith, M, 1988) |
| " Plasma elimination half-life was prolonged, with values ranging from 7:4 to 23." | 1.27 | Pharmacokinetics of cibenzoline in patients with renal impairment. ( Aubert, P; Baglin, A; Canal, M; Flouvat, B; Guedon, J; Prinseau, J, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takahashi, M | 1 |
| Echizen, H | 1 |
| Takahashi, K | 1 |
| Shimada, S | 1 |
| Aoyama, N | 1 |
| Izumi, T | 1 |
| Ozasa, Y | 1 |
| Takamura, S | 1 |
| Seishi, I | 1 |
| Kitada, H | 1 |
| Uekihara, S | 1 |
| Hayano, S | 1 |
| Kasuga, A | 1 |
| Maruyama, H | 1 |
| Sato, T | 1 |
| Nogawa, S | 1 |
| Mitamura, H | 1 |
| Saruta, T | 1 |
| Wakutani, Y | 1 |
| Matsushima, E | 1 |
| Son, A | 1 |
| Shimizu, Y | 1 |
| Goto, Y | 1 |
| Ishida, H | 1 |
| Honda, T | 2 |
| Soejima, H | 1 |
| Aronoff, G | 1 |
| Brier, M | 1 |
| Mayer, ML | 1 |
| Barbalas, M | 1 |
| Aogaichi, K | 2 |
| Sloan, R | 1 |
| Brazzell, R | 1 |
| Massarella, J | 1 |
| Massarella, JW | 1 |
| Khoo, KC | 1 |
| Di Persio, D | 1 |
| Smith, M | 1 |
| Kluger, J | 1 |
| Chow, MS | 1 |
| Canal, M | 1 |
| Flouvat, B | 1 |
| Aubert, P | 1 |
| Guedon, J | 1 |
| Prinseau, J | 1 |
| Baglin, A | 1 |
2 trials available for cifenline and Chronic Kidney Failure
| Article | Year |
|---|---|
Long-term low-dose cibenzoline in patients with chronic renal failure undergoing hemodialysis.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Dose-Respon | 2000 |
Bioavailability and kinetics of cibenzoline in patients with normal and impaired renal function.
Topics: Administration, Oral; Adult; Biological Availability; Half-Life; Humans; Imidazoles; Infusions, Intr | 1991 |
6 other studies available for cifenline and Chronic Kidney Failure
| Article | Year |
|---|---|
Extremely prolonged elimination of cibenzoline at toxic plasma concentrations in patients with renal impairments.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Chromatography, High P | 2002 |
[A case of acute cibenzoline intoxication in a hemodialysis patient].
Topics: Acute Disease; Aged; Anti-Arrhythmia Agents; Bundle-Branch Block; Electrocardiography; Humans; Imida | 2003 |
Myasthenia-like syndrome induced by overdosage of cibenzoline.
Topics: Aged; Anti-Arrhythmia Agents; Aortic Aneurysm; Aortic Dissection; Atrial Fibrillation; Blepharoptosi | 1996 |
Myasthenialike syndrome due to adverse effects of cibenzoline in a patient with chronic renal failure.
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electric Stimulation; Heart Ventricle | 1998 |
Effect of renal impairment on the pharmacokinetics of cibenzoline.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Female; Humans; Imidazoles; Kidney Failur | 1988 |
Pharmacokinetics of cibenzoline in patients with renal impairment.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Creatinine; Female; Half-Life; Humans; Im | 1985 |